SCHEMBL6132091

SCHEMBL6132091

Cc1ccc(-c2[nH]ncc2-c2cccnc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 4/20 0.55
FGFR1 P11362 2/20 0.55
AURKA O14965 1/20 0.55
CDK1 P06493 1/20 0.55
LYN P07948 1/20 0.55
PIM1 P11309 1/20 0.55
PRKACA P17612 1/20 0.55
RPS6KB1 P23443 1/20 0.55
CDK2 P24941 1/20 0.55
MARK3 P27448 1/20 0.55
AKT1 P31749 1/20 0.55
GSK3B P49841 1/20 0.55
PRKCZ Q05513 1/20 0.55
PRKCD Q05655 1/20 0.55
ERBB4 Q15303 1/20 0.55
CDC42BPA Q5VT25 1/20 0.55
MARK2 Q7KZI7 1/20 0.55
AKT3 Q9Y243 1/20 0.55
HPGDS O60760 1/20 0.50
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132062 0.83 RPS6KA3 (0.70) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL6132075 0.82 MAPK14 (0.71) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL4582701 0.75 CYP2A6 (0.68) NPC1RAB9AALDH1A1TP53NFKB1
SCHEMBL260412 0.75 CYP2A6 (0.68) NPC1RAB9AALDH1A1TP53NFKB1
SCHEMBL6132071 0.74 TRPA1 (0.49) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL5248907 0.72 RPS6KA3 (0.81) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL6076343 0.71 RPS6KA3 (1.00) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL13516123 0.71 LMNA (0.67) FGFR1PIM1HPGDSALDH1A1TP53
SCHEMBL6073381 0.71 RPS6KA3 (1.00) RPS6KA3FGFR1AURKACDK1LYN
SCHEMBL9974949 0.71 CYP2A6 (0.56) NPC1RAB9AMAP2K4ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP claimed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP claimed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO claimed